Join
Live feed
·
PRReleasevia Quantisnow
Talaris Therapeutics Inc. logo

Talaris Therapeutics Announces Conference Call to Highlight Presentations at the American Transplant Congress (ATC) and Provide a Data Update from its Phase 3 FREEDOM-1 Study

ByQuantisnow·Wall Street's wire, on your screen.
TALS· Talaris Therapeutics Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track TALS (Talaris Therapeutics Inc.) and more on Quantisnow.